Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancer. Park S, Noh JM, Choi YL, Chi SA, et al. Eur J Cancer 2022;169:42-53.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Park S, Noh JM, Choi YL, Chi SA, et al. Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancer. Eur J Cancer 2022;169:42-53.
PMID: 35500460